198 related articles for article (PubMed ID: 1549956)
1. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium.
Bagi CM; Miller SC
J Bone Miner Res; 1992 Jan; 7(1):29-40. PubMed ID: 1549956
[TBL] [Abstract][Full Text] [Related]
2. Influence of sex steroids on development of cultured fetal rat metatarsal bones.
Chamoux E; Coxam V; Lebecque P; Davicco MJ; Miller SC; Barlet JP
Growth Dev Aging; 1997; 61(2):79-91. PubMed ID: 9348474
[TBL] [Abstract][Full Text] [Related]
3. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
4. A direct effect of 24,25-(OH)2D3 and 1,25-(OH)2D3 on the modeling of fetal mice long bones in vitro.
Schwartz Z; Soskolne WA; Atkin I; Goldstein M; Ornoy A
J Bone Miner Res; 1989 Apr; 4(2):157-63. PubMed ID: 2786320
[TBL] [Abstract][Full Text] [Related]
5. Opposite effects of osteogenic protein and transforming growth factor beta on chondrogenesis in cultured long bone rudiments.
Dieudonné SC; Semeins CM; Goei SW; Vukicevic S; Nulend JK; Sampath TK; Helder M; Burger EH
J Bone Miner Res; 1994 Jun; 9(6):771-80. PubMed ID: 8079653
[TBL] [Abstract][Full Text] [Related]
6. Relationship of the plasminogen activator/plasmin cascade to osteoclast invasion and mineral resorption in explanted fetal metatarsal bones.
Leloup G; Delaisse JM; Vaes G
J Bone Miner Res; 1994 Jun; 9(6):891-902. PubMed ID: 8079664
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3.
van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA
J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1,25-dihydroxyvitamin D3 on prostaglandin E2 production in cultured mouse parietal bones.
Klein-Nulend J; Pilbeam CC; Raisz LG
J Bone Miner Res; 1991 Dec; 6(12):1339-44. PubMed ID: 1838853
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
11. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
Hinek A; Poole AR
J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
[TBL] [Abstract][Full Text] [Related]
12. Picomolar norethindrone in vitro stimulates the cell proliferation and activity of a human osteosarcoma cell line and increases bone collagen synthesis without an effect on bone resorption.
Lau KH; Wang SP; Linkhart TA; Demarest KT; Baylink DJ
J Bone Miner Res; 1994 May; 9(5):695-703. PubMed ID: 8053399
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin D metabolites on collagen production and cell proliferation of growth zone and resting zone cartilage cells in vitro.
Schwartz Z; Schlader DL; Ramirez V; Kennedy MB; Boyan BD
J Bone Miner Res; 1989 Apr; 4(2):199-207. PubMed ID: 2786322
[TBL] [Abstract][Full Text] [Related]
14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
15. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
Leloup G; Lemoine P; Carmeliet P; Vaes G
J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
[TBL] [Abstract][Full Text] [Related]
16. A-ring analogues of 1, 25-(OH)2D3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation.
Greising DM; Schwartz Z; Posner GH; Sylvia VL; Dean DD; Boyan BD
J Cell Physiol; 1997 Jun; 171(3):357-67. PubMed ID: 9180905
[TBL] [Abstract][Full Text] [Related]
17. Differences in metabolism between 26,26,26,27,27,27-hexafluoro-1 alpha, 25-dihydroxyvitamin D3 and 1 alpha, 25-dihydroxyvitamin D3 in cultured neonatal mouse calvaria.
Harada M; Miyahara T; Kajita-Kondo S; Kozakai A; Higuchi S; Otomo S; Kozuka H
Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):183-93. PubMed ID: 7881867
[TBL] [Abstract][Full Text] [Related]
18. [Effect of vitamin D3 and its metabolites 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol on callus mineralization in rats with femoral fracture].
Blazhevich NV; Sergeev IN; Arkhapchev IuP; Isaeva VA; Spirichev VB
Vopr Med Khim; 1982; 28(6):98-105. PubMed ID: 6297167
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human transforming growth factor beta 1 modulates bone remodeling in a mineralizing bone organ culture.
Chen TL; Bates RL
J Bone Miner Res; 1993 Apr; 8(4):423-34. PubMed ID: 8475792
[TBL] [Abstract][Full Text] [Related]
20. Effects of two new vitamin D3 derivatives, 22-oxa-1 alpha-25-dihydroxyvitamin D3 (OCT) and 2 beta-(3-hydroxypropoxy)-1 alpha, 25-dihydroxyvitamin D3 (ED-71), on bone metabolism in organ culture.
Sato K; Nishii Y; Woodiel FN; Raisz LG
Bone; 1993; 14(1):47-51. PubMed ID: 8443002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
